Skip to main content
. 2011 Dec;18(12):2178–2180. doi: 10.1128/CVI.05254-11

Table 1.

Characteristics and H. influenzae colonization status of the study population (n = 342)

Variable Characteristic No. of subjects No. (%) of subjects colonized Distribution of H. influenzae serotypes among subjects P valuea
Age 6–15 mos 88 21 (23.8) 20 NT, 1 e 0.489
16–23 mos 67 22 (32.8) 22 NT
2 yrs 59 15 (25.4) 13 NT, 1 b, 1 e
3 yrs 58 18 (31.0) 17 NT, 1 f
4 yrs 43 8 (18.6) 8 NT
5 yrs 24 9 (37.5) 9 NT
6 yrs 3 1 (33.3) 1 NT
Sex Male 185 63 (34.1) 61 NT, 1 b, 1 e 0.004
Female 157 31 (19.7) 29 NT, 1 e, 1 f
Race/ethnicity White 49 12 (24.5) 11 NT, 1 e 0.874
Black 268 78 (29.1) 75 NT, 1 b, 1 e, 1 f
Hispanic 9 1 (11.1) 1 NT
Asian 5 1 (20.0) 1 NT
Other 10 2 (20.0) 2 NT
Unknown 1 0 (0.0) 0
Antibiotics in past 6 mos No 190 49 (25.8) 45 NT, 1 b, 2 e, 1 f 0.464
Yes 149 44 (29.5) 44 NT
Unknown 3 1 (33.3) 1 NT
Attends day care No 175 37 (21.1) 35 NT, 1 b, 1 e 0.008
Yes 166 57 (34.3) 55 NT, 1 e, 1 f
Vaccination statusb Unvaccinated 18 4 (22.2) 3 NT, 1 b 0.222
Undervaccinated 83 28 (33.7) 27 NT, 1 e
Appropriately vaccinated 194 54 (27.8) 53 NT, 1 e
Incomplete information 47 8 (17.0) 7 NT, 1 f
a

P values for each variable were determined using Fisher's exact test.

b

A subject was considered undervaccinated for age if he or she was 6 to 15 months old and had received less than 3 doses of PRP-T or any combination of vaccine type or less than 2 doses of PRP-OMP vaccine. A subject was considered undervaccinated if older than 15 months and received less than 4 doses of PRP-T or a combination of vaccine type or less than 3 doses of PRP-OMP.